AT333952B - Verfahren zur herstellung von neuen 3-halogencephalosporinverbindungen - Google Patents

Verfahren zur herstellung von neuen 3-halogencephalosporinverbindungen

Info

Publication number
AT333952B
AT333952B AT142474A AT142474A AT333952B AT 333952 B AT333952 B AT 333952B AT 142474 A AT142474 A AT 142474A AT 142474 A AT142474 A AT 142474A AT 333952 B AT333952 B AT 333952B
Authority
AT
Austria
Prior art keywords
halogencephalosporine
compounds
producing new
producing
new
Prior art date
Application number
AT142474A
Other languages
English (en)
Other versions
ATA142474A (de
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of ATA142474A publication Critical patent/ATA142474A/de
Application granted granted Critical
Publication of AT333952B publication Critical patent/AT333952B/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D501/00Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/207-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D501/00Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/02Preparation
    • C07D501/04Preparation from compounds already containing the ring or condensed ring systems, e.g. by dehydrogenation of the ring, by introduction, elimination or modification of substituents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D501/00Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/59Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3 with hetero atoms directly attached in position 3

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Cephalosporin Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT142474A 1973-02-23 1974-02-21 Verfahren zur herstellung von neuen 3-halogencephalosporinverbindungen AT333952B (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US33541473A 1973-02-23 1973-02-23

Publications (2)

Publication Number Publication Date
ATA142474A ATA142474A (de) 1976-04-15
AT333952B true AT333952B (de) 1976-12-27

Family

ID=23311677

Family Applications (1)

Application Number Title Priority Date Filing Date
AT142474A AT333952B (de) 1973-02-23 1974-02-21 Verfahren zur herstellung von neuen 3-halogencephalosporinverbindungen

Country Status (34)

Country Link
JP (4) JPS612677B2 (de)
AR (3) AR208068A1 (de)
AT (1) AT333952B (de)
BE (1) BE811494A (de)
BG (1) BG22404A3 (de)
BR (1) BR7401385D0 (de)
CA (1) CA1032532A (de)
CH (1) CH594686A5 (de)
CS (1) CS189625B2 (de)
CY (1) CY1042A (de)
DD (1) DD110277A5 (de)
DE (1) DE2408686C2 (de)
ES (1) ES423532A1 (de)
FI (1) FI63240C (de)
FR (1) FR2218878B1 (de)
GB (1) GB1458293A (de)
GT (1) GT197432132A (de)
HK (1) HK19980A (de)
HU (1) HU167749B (de)
IE (1) IE38916B1 (de)
IL (1) IL44263A (de)
KE (1) KE3026A (de)
MW (1) MW574A1 (de)
MY (1) MY8100023A (de)
NL (1) NL181010C (de)
NO (2) NO148376C (de)
OA (1) OA04688A (de)
PH (1) PH14014A (de)
PL (1) PL88714B1 (de)
RO (1) RO64595A (de)
SE (1) SE411211B (de)
YU (2) YU36971B (de)
ZA (1) ZA741190B (de)
ZM (1) ZM3674A1 (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT342197B (de) * 1975-02-20 1978-03-28 Ciba Geigy Ag Neues verfahren zur herstellung von 3-cephemverbindungen
CH622802A5 (de) * 1975-08-20 1981-04-30 Ciba Geigy Ag
IE45158B1 (en) * 1976-08-16 1982-06-30 Lilly Co Eli 3-chloro-cephem synthesis
PH17188A (en) * 1977-03-14 1984-06-14 Fujisawa Pharmaceutical Co New cephem and cepham compounds and their pharmaceutical compositions and method of use
JPS62112053U (de) * 1985-12-27 1987-07-16
JPH0676861B2 (ja) * 1988-05-24 1994-09-28 リンナイ株式会社 温風暖房機の制御装置
IT1255458B (it) * 1992-05-11 1995-11-02 Col Marco Da Procedimento per la preparazione di derivati beta-lattamici alogenati

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2143211B1 (de) * 1971-06-24 1975-10-31 Fujisawa Pharmaceutical Co

Also Published As

Publication number Publication date
NO148376B (no) 1983-06-20
GB1458293A (en) 1976-12-15
AU6591574A (en) 1975-08-28
HK19980A (en) 1980-04-25
FR2218878B1 (de) 1977-03-11
FI63240B (fi) 1983-01-31
JPS612677B2 (de) 1986-01-27
JPS56138193A (en) 1981-10-28
AR208068A1 (es) 1976-11-30
FI63240C (fi) 1983-05-10
HU167749B (de) 1975-12-25
CA1032532A (en) 1978-06-06
JPS56138195A (en) 1981-10-28
ES423532A1 (es) 1976-06-01
AR200908A1 (es) 1974-12-27
DE2408686A1 (de) 1974-09-05
BE811494A (fr) 1974-08-22
BG22404A3 (bg) 1977-02-20
ZM3674A1 (en) 1975-11-21
CS189625B2 (en) 1979-04-30
JPS56138194A (en) 1981-10-28
JPS613356B2 (de) 1986-01-31
YU37347B (en) 1984-08-31
NO148376C (no) 1983-09-28
NL181010C (nl) 1987-06-01
IE38916L (en) 1974-08-23
GT197432132A (es) 1975-08-16
NO792609L (no) 1974-08-26
JPS613358B2 (de) 1986-01-31
AR201709A1 (es) 1975-04-08
CH594686A5 (de) 1978-01-31
MY8100023A (en) 1981-12-31
IL44263A0 (en) 1974-05-16
YU46374A (en) 1982-06-18
PH14014A (en) 1980-12-08
NO740607L (no) 1974-08-26
KE3026A (en) 1980-03-14
OA04688A (fr) 1980-07-31
DE2408686C2 (de) 1986-08-28
DD110277A5 (de) 1974-12-12
NL181010B (nl) 1987-01-02
JPS613357B2 (de) 1986-01-31
YU99880A (en) 1983-04-27
SE411211B (sv) 1979-12-10
YU36971B (en) 1984-08-31
RO64595A (ro) 1981-01-30
JPS49116095A (de) 1974-11-06
IL44263A (en) 1977-10-31
ZA741190B (en) 1975-09-24
CY1042A (en) 1980-08-01
MW574A1 (en) 1975-05-13
PL88714B1 (en) 1976-09-30
IE38916B1 (en) 1978-06-21
ATA142474A (de) 1976-04-15
BR7401385D0 (pt) 1974-11-05
NL7402486A (de) 1974-08-27
FR2218878A1 (de) 1974-09-20

Similar Documents

Publication Publication Date Title
AT335419B (de) Verfahren zur herstellung von neuen 2-cyclohexen-1-on-derivaten
AT341119B (de) Verfahren zur herstellung von neuen prostanderivaten
AT340397B (de) Verfahren zur herstellung von neuen polyenverbindungen
AT326137B (de) Verfahren zur herstellung von neuen 3-phenyl-6-halogen-pyridanzinverbindungen
AT336555B (de) Verfahren zur herstellung von neuen athoxylierten hydroxyathern
ATA1021774A (de) Verfahren zur herstellung von neuen pregnan-21-saeure-derivaten
AT341689B (de) Verfahren zur herstellung von neuen octapeptiden
AT351180B (de) Verfahren zur herstellung von neuen d-homo- steroiden
AT335607B (de) Verfahren zur herstellung von neuen beta-lactamantibiotica
AT336575B (de) Verfahren zur herstellung von neuen p-hydroxyphenylalkanalen
AT333429B (de) Verfahren zur herstellung von neuen 7beta-acylamido -7alpha- methoxycephalosporinverbindungen
AT333952B (de) Verfahren zur herstellung von neuen 3-halogencephalosporinverbindungen
AT338240B (de) Verfahren zur herstellung von neuen phenoxyathylaminen
AT339296B (de) Verfahren zur herstellung von neuen xanthenderivaten
AT330160B (de) Verfahren zur herstellung von neuen biphenyl-derivaten
AT326145B (de) Verfahren zur herstellung von neuen phosphonoureidoverbindungen
AT332971B (de) Verfahren zur herstellung von neuen cephalosporinverbindungen
ATA169774A (de) Verfahren zur herstellung von neuen isonitrilen
ATA874574A (de) Verfahren zur herstellung von neuen 1-phthalazonderivaten
AT336812B (de) Verfahren zur herstellung von neuen 21-fluor-19-norpregnadienverbindungen
ATA576675A (de) Verfahren zur herstellung von neuen 21-fluor-19-norpregnadienverbindungen
ATA576575A (de) Verfahren zur herstellung von neuen 21-fluor-19-norpregnadienverbindungen
ATA576475A (de) Verfahren zur herstellung von neuen 21-fluor-19-norpregnadienverbindungen
AT333958B (de) Verfahren zur herstellung von neuen cephalosporinantibiotica
ATA471176A (de) Verfahren zur herstellung von neuen 1-phthalazonderivaten

Legal Events

Date Code Title Description
ELJ Ceased due to non-payment of the annual fee
EWE Authorization for restitution
ELA Expired due to lapse of time
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties